Tumor necrosis factor-α inhibitors may induce various cutaneous side effects including eczematous-like lesions. The management of such side effects can be challenging. Herein, we report a case of a 55-year-old man who had a flare-up and subsequent improvement of atopic dermatitis during treatment of severe psoriasis with adalimumab
Atopic dermatitis (AD) is a common inflammatory skin condition that affects up to 20-30% of children...
Atopic dermatitis (AD) is a chronic, multifactorial, inflammatory skin disease which can have a nega...
Despite recent advances in understanding the pathological pathways, clinical pattern and manageme...
Tumor necrosis factor-α inhibitors may induce various cutaneous side effects including eczematous-li...
Alopecia induced by biological therapy is a rare side effect of this type of drugs. A total of 23 pa...
AbstractAdalimumab is a fully human immunoglobulin G1 monoclonal antibody against tumor necrosis fac...
Anti-tumor necrosis factor (anti-TNF) agents have been successfully used to treat both chronic idiop...
Adalimumab is a fully human immunoglobulin G1 monoclonal antibody against tumor necrosis factor (TNF...
Tumor necrosis factor-alpha antagonists include monoclonal antibodies, infliximab, adalimumab, etane...
none6noneEl Shabrawi-Caelen L.; La Placa M.; Vincenzi C.; Haidn T.; Muellegger R.; Tosti A.El Shabra...
Anti-TNF drugs may be associated with various adverse reactions including cutaneous ones. We describ...
Recent reports indicate different side-effects of the new medication for psoriasis. Adalimumab. Adal...
Psoriasis is a polygenic, systemic inflammatory disease seen in 2% to 3% of the population and leads...
In recent years, with the increase usage of tumor necrosis factor (TNF) inhibitors, more side effect...
We report phenotypic switching from atopic dermatitis to psoriasis in a 44-year-old man during treat...
Atopic dermatitis (AD) is a common inflammatory skin condition that affects up to 20-30% of children...
Atopic dermatitis (AD) is a chronic, multifactorial, inflammatory skin disease which can have a nega...
Despite recent advances in understanding the pathological pathways, clinical pattern and manageme...
Tumor necrosis factor-α inhibitors may induce various cutaneous side effects including eczematous-li...
Alopecia induced by biological therapy is a rare side effect of this type of drugs. A total of 23 pa...
AbstractAdalimumab is a fully human immunoglobulin G1 monoclonal antibody against tumor necrosis fac...
Anti-tumor necrosis factor (anti-TNF) agents have been successfully used to treat both chronic idiop...
Adalimumab is a fully human immunoglobulin G1 monoclonal antibody against tumor necrosis factor (TNF...
Tumor necrosis factor-alpha antagonists include monoclonal antibodies, infliximab, adalimumab, etane...
none6noneEl Shabrawi-Caelen L.; La Placa M.; Vincenzi C.; Haidn T.; Muellegger R.; Tosti A.El Shabra...
Anti-TNF drugs may be associated with various adverse reactions including cutaneous ones. We describ...
Recent reports indicate different side-effects of the new medication for psoriasis. Adalimumab. Adal...
Psoriasis is a polygenic, systemic inflammatory disease seen in 2% to 3% of the population and leads...
In recent years, with the increase usage of tumor necrosis factor (TNF) inhibitors, more side effect...
We report phenotypic switching from atopic dermatitis to psoriasis in a 44-year-old man during treat...
Atopic dermatitis (AD) is a common inflammatory skin condition that affects up to 20-30% of children...
Atopic dermatitis (AD) is a chronic, multifactorial, inflammatory skin disease which can have a nega...
Despite recent advances in understanding the pathological pathways, clinical pattern and manageme...
DOI
Add to ORKG